Τίτλος:
Systematic review non-vitamin K oral anticoagulants in adults with congenital heart disease
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Adults with congenital heart disease (ACHD) experience more thromboembolic complications than the general population. We systematically searched and critically appraised all studies on the safety and efficacy of non-vitamin-K oral anticoagulants (NOACs) in adult patients with various forms of congenital heart disease. PubMed and the Cochrane Central Register of Controlled Trials (CENTRAL) were used, with duplicate extraction of data and risk of bias assessment. The Newcastle-Ottawa quality assessment scale was used to assess study quality. Three studies fulfilled the inclusion criteria and were analyzed. The total number of participants was 766, with a total follow-up of 923 patient-years. The majority of patients (77%) received a NOAC for atrial arrhythmias, while the remainder were prescribed NOACs for secondary (19%) or primary (4%) thromboprophylaxis. The annual rate of thromboembolic and major bleeding events was low: 0.98% (95% CI: 0.51–1.86) and 1.74% (95% CI: 0.86–3.49) respectively. In Fontan patients, the annual rate of thromboembolic and major bleeding events was 3.13% (95% CI: 1.18–8.03) and 3.17% (95% CI: 0.15–41.39) respectively. NOACs appear safe and effective in ACHD without mechanical prostheses. Additional studies are, however, needed to confirm their efficacy in complex ACHD, especially those with a Fontan-type circulation. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Συγγραφείς:
Stalikas, N.
Doundoulakis, I.
Karagiannidis, E.
Bouras, E.
Kartas, A.
Frogoudaki, A.
Karvounis, H.
Dimopoulos, K.
Giannakoulas, G.
Περιοδικό:
Journal of Clinical Medicine Research
Λέξεις-κλειδιά:
vitamin K group, anticoagulation; Article; disease severity; follow up; heart atrium arrhythmia; heart disease; human; meta analysis; outcome assessment; quality control; quality of life; systematic review; tachycardia; thromboembolism
